Kullback–Leibler Divergence for Evaluating Equivalence

Authored by: Vladimir Dragalin

Encyclopedia of Biopharmaceutical Statistics

Print publication date:  August  2018
Online publication date:  August  2018

Print ISBN: 9781498733953
eBook ISBN: 9781351110273
Adobe ISBN:


 Download Chapter



Kullback–Leibler Divergence for Evaluating Equivalence The Kullback-Leibler divergence metric is a viable alternative to that proposed by the FDA for the assessment of bioequivalence. This entry details the benefits of this type of bioequivalence study by providing models for use.

Search for more...
Back to top

Use of cookies on this website

We are using cookies to provide statistics that help us give you the best experience of our site. You can find out more in our Privacy Policy. By continuing to use the site you are agreeing to our use of cookies.